Abstract:

During this webinar, our experts will share insights on how our cutting-edge AAV transient transfection and producer cell line platforms can significantly accelerate your journey towards Investigational New Drug (IND) application success.

Current AAV manufacturing faces challenges such as low productivity, high costs, and supply chain issues. Lonza’s Xcite® AAV platforms, leveraging transient transfection and stable producer cell line (PCL) technologies, offer innovative solutions to these challenges.

Speakers: Suparna Sanyal, PhD, Head of Commercial Development Viral Vectors; Bingnan Gu, PhD, Head of R&D Viral Vectors

You may also be interested in:
Viral Vectors
Out-Licensed Expression Technologies
Analytical Development
Process Development and Optimization
Viral Vector Expression Technologies
Viral Vector Expression Technologies
By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest content
Latest briefing from the Knowledge Center
Houston, TX facility,Woman working in lab,PD scientist in lab,CGT Houston Process Development
Technical/Service brief
Translating Exosome Candidates into Approved Therapies with engEx® Platform Technologies
Exosomes represent one type of extracellular vesicle (EV) generated by all eukaryotic cells....
Article
An interview with Lisa Prendergast for Next Generation Gene Therapy Vectors Conference
Dr. Lisa Prendergast leads innovation for Lonza's Licensing Business Unit, supporting the growth of...
Cocoon device
Technical/Service brief
Cocoon® CAR-T™: Manufacturing Cell Therapies in the Lonza Cocoon® Platform - 9-day Process
Performance data of the 9-day process for functionally-closed and automated manufacture of...
Webinar (on-demand)
Enhancing CAR-T Therapy Development - Harnessing Cell Selection Flexibility
Abstract: During this webinar, our experts will explore recent developments that highlight the...
Technical/Service brief
GMP Tissue Sourcing
A complex process, prone to misconceptions and pitfalls, to find the “right human tissue” that will...
Webinar (on-demand)
Extracellular Vesicles - Setting-Up the Path to IND With Advanced Characterization Packages
Abstract: During this webinar, our expert will share insights on how precise analytics and process...
Technical/Service brief
End-To-End Production of T Cells on the Cocoon® Platform, Using Buoyancy-Activated Cell Sorting™ For...
Performance data of the Cocoon® Platform using Buoyancy-Activated Cell Sorting™ for T cell isolation...
Article
Meet Your Lentiviral Vector Development and Supply Requirements with Xcite® Lenti, an Optimized...
Demand for lentiviral vectors (LVVs) as delivery vehicles for gene therapies is rising...
Webinar (on-demand)
AAV Transient Transfection and Producer Cell Line Platforms to Accelerate your Path to IND
Abstract: During this webinar, our experts will share insights on how our cutting-edge AAV...
Poster
3D Linkage Analysis with Digital PCR for rAAV Characterization Beyond Genomic Titer: Integrity and...
Abstract: Recombinant adeno-associated virus (rAAV) has emerged as the vector of choice for in vivo...
Dev on Demand - CGT - process development
Poster
Extracellular Vesicles: Engineering New Therapeutic Delivery Modalities
Abstract: Extracellular Vesicles (EVs), including exosomes, are emerging as promising natural...
Poster
Plasmid Engineering to Improve AAV Productivity and Packaging Efficiency
Abstract: The genome packaging efficiency (full to total capsid ratio, or F/T ratio) for...